About
BLD Pharmatech helps pharmaceutical, biotech, and research organizations accelerate discovery and development through reliable chemical supply and custom synthesis services. With 700,000+ catalog compounds and 120,000+ in-stock items across global warehouses in the US, Europe, and Asia, we ensure fast delivery and flexible sourcing to support time-sensitive research programs. Beyond standard catalog products, we provide end-to-end solutions including custom synthesis, process development, and scale-up manufacturing — helping partners move seamlessly from early discovery to advanced development. Our team of experienced chemists works closely with clients to solve complex synthetic challenges, reduce lead times, and optimize project outcomes. Trusted by pharmaceutical companies, biotech firms, CROs, and academic institutions worldwide, BLDpharm is committed to quality, reliability, and long-term collaboration. Why BLDpharm? · 700,000+ research products · 120,000+ in-stock · Fast global delivery · ISO 9001, ISO 14001 and ISO 45001 certified · Custom Synthesis · Scale-up Manufacturing · Medicinal Chemistry Support · Preparative Chromatography (Prep-HPLC, Prep-SFC, Prep-NPLC) · Method Development & Chiral Separation · FTE/FFS services · Global Supply Chain Looking for a reliable partner in chemical sourcing or custom synthesis? Contact us to discuss your project. https://www.bldpharm.com/contacts-us.html
Articles
From FDA-Approved Iberdomide: CRBN Lignads
Iberdomide (CC-220), marketed as Zenbexus by Bristol-Myers Squibb (BMS), received accelerated FDA approval on August 13, 2026.